United States · FDA National Drug Code directory
Shingrix
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 50090-7919_3cc5ee17-3376-493a-8146-42df66edb945
- Product NDC
- 50090-7919
- Form
- INJECTION, SOLUTION
- Composition / generic term
- Zoster Vaccine Recombinant, Adjuvanted
- Labeler
- A-S Medication Solutions
- Marketing category
- BLA
- Marketing start / end (source format)
- 20250716
- Source listing expiry
- 20271231
Source-listed ingredients
- RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEIN E ANTIGEN — 50 ug/.5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 mL in 1 KIT (50090-7919-0) · 50090-7919-0
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →